Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

The role of TET2 in (pre)-leukemic T-cell acute lymphoblastic leukemia

Information

Project Team

Organisations

Outputs and Outcomes

Publications

Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia

Stien De ConinckJuliette RoelsBéatrice LintermansSara T'SasTom TaghonDavid CurtisTim PietersSteven GoossensPieter Van Vlierberghe

A1 Journal Article in BLOOD ADVANCES

2024

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma

Lien ProvezTom PuttemanMattias LandforsJuliette RoelsLindy ReunesSara T'SasWouter Van LoockeBéatrice LintermansStien De ConinckMorgan ThénozWouter SleeckxNatalia Mackowska-MaslakTom TaghonMarc R. MansourNadine FarahKoen NorgaPeter VandenbergheRishi S. KotechaSteven GoossensSofie DegermanRenate De SmedtPieter Van Vlierberghe et al.

U Journal Article in CANCERS

2023

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

Juliette RoelsMorgan ThénozB SzarzyńskaM LandforsStien De ConinckLisa DemoenLien ProvezAnna KuchmiySteven StrubbeLindy ReunesTim PietersFilip MatthijssensWouter Van LoockeB Erarslan-UysalP Richter-PechańskaK DeclerckTim LammensBarbara De MoerlooseDieter DeforceFilip Van NieuwerburghLC CheungRS KotechaMR MansourB GhesquièreG Van CampWV BergheJR KowalczykT SzczepańskiUP DavéAE KulozikSteven GoossensDJ CurtisTom TaghonM DawidowskaS DegermanPieter Van Vlierberghe et al.

A2 Journal Article in BLOOD CANCER DISCOVERY

2020